128 related articles for article (PubMed ID: 36595988)
1. Implantation of computed tomography-guided high-dose-rate 192Ir brachytherapy in oldest old patients with advanced non-small cell lung cancer: A case report and literature review.
Cui R; Wang XL; Cao J
Medicine (Baltimore); 2022 Dec; 101(52):e32450. PubMed ID: 36595988
[TBL] [Abstract][Full Text] [Related]
2. Computed Tomography-Guided Interstitial High-Dose-Rate Brachytherapy in Combination With Regional Positive Lymph Node Intensity-Modulated Radiation Therapy in Locally Advanced Peripheral Non-Small Cell Lung Cancer: A Phase 1 Clinical Trial.
Xiang L; Zhang JW; Lin S; Luo HQ; Wen QL; He LJ; Shang CL; Ren PR; Yang HR; Pang HW; Yang B; He HL; Chen Y; Wu JB
Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1027-1034. PubMed ID: 26194678
[TBL] [Abstract][Full Text] [Related]
3. Image-Guided Brachytherapy a Comparison Between 192Ir and 60Co Sources in Carcinoma Uterine Cervix.
Sinnatamby M; Kandasamy S; Karunanidhi G; Neelakandan V; Ramapandian S; Kannan M; Sampath E
Gulf J Oncolog; 2022 Jan; 1(38):7-14. PubMed ID: 35156639
[TBL] [Abstract][Full Text] [Related]
4. IRIDIUM-192 RADIOTHERAPY BENEFITS IN THE MANAGEMENT OF GYNECOLOGICAL TUMORS.
Ivankova VS; Domina EA; Khrulenko TV; Baranovska LM; Hrinchenko OO
Probl Radiac Med Radiobiol; 2020 Dec; 25():569-578. PubMed ID: 33361862
[TBL] [Abstract][Full Text] [Related]
5. High dose rate afterloading intraluminal brachytherapy in malignant airway obstruction of lung cancer.
Chang LF; Horvath J; Peyton W; Ling SS
Int J Radiat Oncol Biol Phys; 1994 Feb; 28(3):589-96. PubMed ID: 7509330
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous brachytherapy for small-sized non-small cell lung cancer.
Imamura F; Chatani M; Nakayama T; Uda H; Nakamura S; Horai T
Lung Cancer; 1999 Jun; 24(3):169-74. PubMed ID: 10460004
[TBL] [Abstract][Full Text] [Related]
7. 192Ir or 125I prostate brachytherapy as a boost to external beam radiotherapy in locally advanced prostatic cancer: a dosimetric point of view.
Nickers P; Thissen B; Jansen N; Deneufbourg JM
Radiother Oncol; 2006 Jan; 78(1):47-52. PubMed ID: 16216365
[TBL] [Abstract][Full Text] [Related]
8. Effect and toxicity of endoluminal high-dose-rate (HDR) brachytherapy in centrally located tumors of the upper respiratory tract.
Harms W; Schraube P; Becker H; Latz D; Herth F; Fritz P; Wannenmacher M
Strahlenther Onkol; 2000 Feb; 176(2):60-6. PubMed ID: 10697652
[TBL] [Abstract][Full Text] [Related]
9. Radiobiological and dosimetric comparison of 60Co versus 192Ir high-dose-rate intracavitary-interstitial brachytherapy for cervical cancer.
Wen A; Wang X; Wang B; Yan C; Luo J; Wang P; Li J
Radiat Oncol; 2022 Dec; 17(1):206. PubMed ID: 36514118
[TBL] [Abstract][Full Text] [Related]
10. Computed tomography-guided interstitial high-dose-rate brachytherapy in the local treatment of primary and secondary intrathoracic malignancies.
Tselis N; Ferentinos K; Kolotas C; Schirren J; Baltas D; Antonakakis A; Ackermann H; Zamboglou N
J Thorac Oncol; 2011 Mar; 6(3):545-52. PubMed ID: 21258257
[TBL] [Abstract][Full Text] [Related]
11. Comparison of radiation shielding requirements for HDR brachytherapy using 169Yb and 192Ir sources.
Lymperopoulou G; Papagiannis P; Sakelliou L; Georgiou E; Hourdakis CJ; Baltas D
Med Phys; 2006 Jul; 33(7):2541-7. PubMed ID: 16898458
[TBL] [Abstract][Full Text] [Related]
12. Endobronchial brachytherapy with high-dose-rate remote afterloading for recurrent endobronchial lesions.
Delclos ME; Komaki R; Morice RC; Allen PK; Davis M; Garden A
Radiology; 1996 Oct; 201(1):279-82. PubMed ID: 8816560
[TBL] [Abstract][Full Text] [Related]
13. A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer.
Mattiucci GC; Autorino R; Tringali A; Perri V; Balducci M; Deodato F; Gambacorta MA; Mantini G; Tagliaferri L; Mutignani M; Morganti AG
Brachytherapy; 2015; 14(3):401-4. PubMed ID: 25591935
[TBL] [Abstract][Full Text] [Related]
14. [Endoluminal HDR brachytherapy in the palliative treatment of patients with the recurrence of a non-small-cell bronchial carcinoma after prior radiotherapy].
Micke O; Prott FJ; Schäfer U; Wagner W; Pötter R; Willich N
Strahlenther Onkol; 1995 Oct; 171(10):554-9. PubMed ID: 8571174
[TBL] [Abstract][Full Text] [Related]
15. A dosimetric comparison of 169Yb and 192Ir for HDR brachytherapy of the breast, accounting for the effect of finite patient dimensions and tissue inhomogeneities.
Lymperopoulou G; Papagiannis P; Angelopoulos A; Karaiskos P; Georgiou E; Baltas D
Med Phys; 2006 Dec; 33(12):4583-9. PubMed ID: 17278810
[TBL] [Abstract][Full Text] [Related]
16. Primary radiotherapy with endobronchial high-dose-rate brachytherapy boost for inoperable lung cancer: long-term results.
Rochet N; Hauswald H; Stoiber EM; Hensley FW; Becker HD; Debus J; Lindel K
Tumori; 2013; 99(2):183-90. PubMed ID: 23748812
[TBL] [Abstract][Full Text] [Related]
17. Four year clinical statistics of iridium-192 high dose rate brachytherapy.
Shigehara K; Mizokami A; Komatsu K; Koshida K; Namiki M
Int J Urol; 2006 Feb; 13(2):116-21. PubMed ID: 16563134
[TBL] [Abstract][Full Text] [Related]
18. Recommendations for implementation of high dose rate 192Ir brachytherapy in developing countries by the Advisory Group of International Atomic Energy Agency.
Nag S; Dally M; de la Torre M; Tatsuzaki H; Kizilbash N; Kurusun S; Pinillos L; Pokrajac B; Sur R; Levin V
Radiother Oncol; 2002 Sep; 64(3):297-308. PubMed ID: 12242118
[TBL] [Abstract][Full Text] [Related]
19. High dose rate brachytherapy in patients with local recurrences after radiotherapy of non-small cell lung cancer.
Sutedja G; Baris G; Schaake-Koning C; van Zandwijk N
Int J Radiat Oncol Biol Phys; 1992; 24(3):551-3. PubMed ID: 1383178
[TBL] [Abstract][Full Text] [Related]
20. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
